Omics Edge is a bioinformatics company that specializes in precision health solutions, leveraging advanced technologies to provide organizations with tools for genomic analysis and personalized health insights. Their flagship offerings include Ancestry-Adjusted Polygenic Risk Scores (PRS), which deliver precise genetic health insights across diverse populations, and a powerful genetic imputation tool named Selphi, which excels in accuracy, particularly for rare variants. Additionally, their proprietary genomic compression algorithm achieves a remarkable compression ratio of over 100:1, enabling efficient storage and analysis of large genomic datasets. These technologies are designed to enhance the capabilities of health companies, hospitals, and pharmaceutical firms, facilitating the development of tailored health products and improving patient care.

The company also emphasizes the importance of integrating AI with bioinformatics to optimize health solutions. Their platform supports a wide range of applications, from providing detailed genetic and laboratory reports to generating personalized wellness recommendations based on individual genetic profiles. Omics Edge's technology is designed to streamline operations for health organizations, offering flexible integration options and ensuring compliance with data privacy regulations. By focusing on accuracy and reliability, Omics Edge positions itself as a leader in the genomics industry, empowering businesses to deliver innovative and effective health solutions to their customers.

United States

Omics Edge is a bioinformatics company that integrates AI with bioinformatics to yield portable Polygenic Risk Scores that work across ancestries and ethnicities.

Omics Edge

Company Details